Literature DB >> 20192977

Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease.

N A Aziz1, G V Anguelova, J Marinus, J G van Dijk, R A C Roos.   

Abstract

BACKGROUND AND
PURPOSE: Although autonomic function tests have revealed abnormalities of the autonomic nervous system in Huntington's disease (HD), autonomic symptoms and their association with other symptoms and signs of HD have not yet been assessed in large groups of patients or pre-manifest mutation carriers. Therefore, we aimed at delineating the characteristics and correlates of autonomic symptoms in HD.
METHODS: Using the scales for outcomes in Parkinson's disease-autonomic symptoms (SCOPA-AUT) and Beck Depression Inventory questionnaires, autonomic symptoms and depressed mood were assessed in 63 patients with HD, 21 pre-manifest mutation carriers, and 85 controls. The Unified Huntington's Disease Rating Scale was used to assess other HD symptoms and signs.
RESULTS: Relative to controls, patients with HD experienced significantly more gastrointestinal, urinary, cardiovascular and, in men, sexual problems. The most prevalent symptoms were swallowing difficulties, erection and ejaculation problems, dysphagia, sialorrhea, early abdominal fullness, straining for defecation, fecal and urinary incontinence, urgency, incomplete bladder emptying, and light-headedness whilst standing. Pre-manifest mutation carriers experienced significantly more swallowing difficulties and light-headedness on standing up compared with controls. In patients with HD, autonomic symptoms were associated with a greater degree of functional disability, more severe depression, and antidepressant drugs use. However, depression was the only independent predictor of autonomic dysfunction.
CONCLUSIONS: Autonomic symptoms are highly prevalent in patients with HD and may even precede the onset of motor signs. Moreover, autonomic dysfunction is related to functional disability and depression in HD.

Entities:  

Mesh:

Year:  2010        PMID: 20192977     DOI: 10.1111/j.1468-1331.2010.02973.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  29 in total

1.  Microcirculation response to local cooling in patients with Huntington's disease.

Authors:  Ziva Melik; Jan Kobal; Ksenija Cankar; Martin Strucl
Journal:  J Neurol       Date:  2011-10-20       Impact factor: 4.849

2.  Dysautonomia is frequent in Machado-Joseph disease: clinical and neurophysiological evaluation.

Authors:  Karen A G Takazaki; Anelyssa D'Abreu; Anamarli Nucci; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

3.  Bladder dysfunction in presymptomatic gene carriers and patients with Huntington's disease.

Authors:  Matej Kolenc; Metka Moharić; Jan Kobal; Simon Podnar
Journal:  J Neurol       Date:  2014-09-20       Impact factor: 4.849

4.  Dominant hemisphere lateralization of cortical parasympathetic control as revealed by frontotemporal dementia.

Authors:  Christine C Guo; Virginia E Sturm; Juan Zhou; Efstathios D Gennatas; Andrew J Trujillo; Alice Y Hua; Richard Crawford; Lara Stables; Joel H Kramer; Katherine Rankin; Robert W Levenson; Howard J Rosen; Bruce L Miller; William W Seeley
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 11.205

5.  Aberrant heart rate and brainstem brain-derived neurotrophic factor (BDNF) signaling in a mouse model of Huntington's disease.

Authors:  Kathleen J Griffioen; Ruiqian Wan; Tashalee R Brown; Eitan Okun; Simonetta Camandola; Mohamed R Mughal; Terry M Phillips; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2011-12-31       Impact factor: 4.673

6.  Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease.

Authors:  Helen Kiriazis; Nicole L Jennings; Pamela Davern; Gavin Lambert; Yidan Su; Terence Pang; Xin Du; Luisa La Greca; Geoffrey A Head; Anthony J Hannan; Xiao-Jun Du
Journal:  J Physiol       Date:  2012-08-13       Impact factor: 5.182

7.  Progressive cardiac arrhythmias and ECG abnormalities in the Huntington's disease BACHD mouse model.

Authors:  Yujie Zhu; Isaac Shamblin; Efrain Rodriguez; Grace E Salzer; Lita Araysi; Katherine A Margolies; Ganesh V Halade; Silvio H Litovsky; Steven Pogwizd; Michelle Gray; Sabine Huke
Journal:  Hum Mol Genet       Date:  2020-02-01       Impact factor: 6.150

Review 8.  Progress in Huntington's disease: the search for markers of disease onset and progression.

Authors:  Sarah Mason; Roger A Barker
Journal:  J Neurol       Date:  2015-03-21       Impact factor: 4.849

9.  Cognitive and autonomic dysfunction in presymptomatic and early Huntington's disease.

Authors:  Jan Kobal; Ziva Melik; Ksenija Cankar; Martin Strucl
Journal:  J Neurol       Date:  2014-04-02       Impact factor: 4.849

10.  Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease.

Authors:  Tatiana Aldaz; Pasquale Nigro; Almudena Sánchez-Gómez; Celia Painous; Lluís Planellas; Pilar Santacruz; Ana Cámara; Yaroslau Compta; Francesc Valldeoriola; Maria J Martí; Esteban Muñoz
Journal:  J Neurol       Date:  2019-03-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.